MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer | |
Wang, Chuntao; Liu, Yanliang; Guo, Wenyi; Zhu, Xu; Ahuja, Nita; Fu, Tao | |
刊名 | CANCER MANAGEMENT AND RESEARCH
![]() |
2019 | |
卷号 | 11 |
关键词 | colorectal cancer methylation MAPT prognosis |
ISSN号 | 1179-1322 |
DOI | 10.2147/CMAR.S206731 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4215973 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Wang, Chuntao,Liu, Yanliang,Guo, Wenyi,et al. MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer[J]. CANCER MANAGEMENT AND RESEARCH,2019,11. |
APA | Wang, Chuntao,Liu, Yanliang,Guo, Wenyi,Zhu, Xu,Ahuja, Nita,&Fu, Tao.(2019).MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer.CANCER MANAGEMENT AND RESEARCH,11. |
MLA | Wang, Chuntao,et al."MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer".CANCER MANAGEMENT AND RESEARCH 11(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论